Editorial Commentary: Be Careful With Preoperative Injections Prior to Hip Arthroscopy-Use a Three-Month Threshold to

Insights

Preoperative hip injections increase the risk of postarthroscopic hip infection. Patients receiving injections within three months of surgery faced a significantly higher infection risk compared to controls.

Area of Science:

  • Orthopedic Surgery
  • Infectious Disease Epidemiology
  • Health Services Research

Background:

  • Evaluating the risk of postarthroscopic hip infection in patients who received preoperative injections.
  • Utilizing data from a large private insurer and Medicare in the United States.

Discussion:

  • A 3-month threshold was established for increased infection risk.
  • Significant risk observed for both privately insured and Medicare patients undergoing injections within 3 months of hip arthroscopy.

Key Insights:

  • Postarthroscopic hip infection risk is elevated with preoperative injections within 3 months of surgery.
  • Odds ratios indicate a substantial increase in infection risk (OR 6.1 for private insurance, OR 2.0 for Medicare).
  • P-values confirm statistical significance for the observed increased risk.

Outlook:

  • Further research may explore optimal timing for preoperative injections to mitigate infection risk.
  • This evidence can inform clinical guidelines regarding the use of preoperative injections before hip arthroscopy.